Entasis Therapeutics has a total of 318 patents globally, out of which 224 have been granted. Of these 318 patents, more than 84% patents are active. United States of America is where Entasis Therapeutics has filed the maximum number of patents, followed by Japan and China. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Entasis Therapeutics.
Founded in 2015, Entasis Therapeutics, a subsidiary of Innoviva Inc, is a biotechnology company focused on developing innovative treatments for serious drug-resistant bacterial infections. Its pipeline includes novel clinical and preclinical antibacterial therapies aimed at addressing one of the world’s most pressing public health challenges. The company is committed to advancing next-generation antibiotics to improve outcomes for patients with severe bacterial infections.
Do read about some of the most popular patents of Entasis Therapeutics which have been covered by us in this article and also you can find Entasis Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Entasis Therapeutics patent portfolio.
How many patents does Entasis Therapeutics have?
Entasis Therapeutics has a total of 318 patents globally. These patents belong to 24 unique patent families. Out of 318 patents, 271 patents are active.
How Many Patents did Entasis Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Entasis Therapeutics Applications Filed | Entasis Therapeutics Patents Granted |
| 2026 | 2 | 6 |
| 2025 | 3 | 12 |
| 2024 | 14 | 17 |
| 2023 | 9 | 17 |
| 2022 | 16 | 29 |
| 2021 | 1 | 16 |
| 2020 | 21 | 25 |
| 2019 | 13 | 33 |
| 2018 | 36 | 18 |
| 2017 | 41 | 20 |
How many Entasis Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Entasis Therapeutics File in Different Countries?
Countries in which Entasis Therapeutics Filed Patents
| Country | Patents |
| United States of America | 21 |
| Japan | 14 |
| China | 13 |
| Canada | 13 |
| Europe (EPO) | 12 |
| Korea (South) | 11 |
| Hong Kong (S.A.R.) | 10 |
| Israel | 9 |
| Australia | 9 |
| Singapore | 9 |
| Mexico | 9 |
| Germany | 9 |
| South Africa | 8 |
| New Zealand | 8 |
| Brazil | 8 |
| Austria | 7 |
| Eurasia | 7 |
| Philippines | 7 |
| Taiwan | 7 |
| Spain | 7 |
| India | 6 |
| Malaysia | 6 |
| Denmark | 6 |
| Thailand | 6 |
| Cyprus | 5 |
| Slovenia | 5 |
| Malta | 5 |
| Poland | 5 |
| Croatia | 5 |
| Hungary | 5 |
| Italy | 5 |
| Lithuania | 5 |
| Norway | 5 |
| Portugal | 5 |
| Turkey | 4 |
| Albania | 4 |
| Slovakia | 3 |
| Macao | 3 |
| Serbia | 3 |
| Montenegro | 3 |
| Estonia | 3 |
| Argentina | 2 |
| Chile | 1 |
| Peru | 1 |
| Russia | 1 |
| France | 1 |
Where are Research Centres of Entasis Therapeutics Patents Located?
10 Best Entasis Therapeutics Patents
US7439253B2 is the most popular patent in the Entasis Therapeutics portfolio. It has received 59 citations so far from companies like Merck Sharp & Dohme, Naeja Pharmaceutical Inc and Rempex Pharmaceuticals Inc.
Below is the list of 10 most cited patents of Entasis Therapeutics:
| Publication Number | Citation Count |
| US7439253B2 | 59 |
| US8658641B2 | 52 |
| WO2016081452A1 | 27 |
| US8148540B2 | 26 |
| US7288549B2 | 26 |
| WO2018053215A1 | 17 |
| WO2014114929A1 | 13 |
| WO2017203266A1 | 12 |
| US8889671B2 | 10 |
| WO2018208769A1 | 9 |
What Percentage of Entasis Therapeutics US Patent Applications were Granted?
Entasis Therapeutics (Excluding its subsidiaries) has filed 19 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 16 have been granted leading to a grant rate of 94.12%.
Below are the key stats of Entasis Therapeutics patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Entasis Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Mccarter & English Llp | 13 | 90.91% |
| Astrazeneca Medimmune | 5 | 100.00% |
| Harness Dickey Troy | 1 | 100.00% |
What are Entasis Therapeutics key innovation segments?
What Technologies are Covered by Entasis Therapeutics?
The chart below distributes patents filed by Entasis Therapeutics